Trials / Completed
CompletedNCT04277507
Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction
A Prospective, Multicenter Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction (AERWAY)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Aerin Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Post-market study to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for nasal airway obstruction
Detailed description
Prospective, Multicenter, Non-randomized Study of the Aerin Medical Vivaer® ARC Stylus for Nasal Airway Obstruction to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for treating the nasal valve area to improve symptoms in those diagnosed with nasal airway obstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vivaer Stylus | Delivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area |
Timeline
- Start date
- 2020-02-07
- Primary completion
- 2020-12-31
- Completion
- 2024-10-11
- First posted
- 2020-02-20
- Last updated
- 2025-05-04
- Results posted
- 2023-05-25
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04277507. Inclusion in this directory is not an endorsement.